Other featured articles
New Payment Strategy Could Help States Treat More Hepatitis C Patients While Encouraging Innovation
A curative treatment exists for chronic hepatitis C infection, yet many Medicaid beneficiaries do not have access to these drugs. Neeraj Sood and his colleagues have developed a novel pricing strategy to expand access.
The Case for Reforming Competitive Bidding in Medicare Advantage
Schaeffer Initiative experts propose reforming the way that fixed monthly payments to MA plans are determined, replacing the current, overly complex structure with one that would enhance competition, simplify beneficiary choice through standardization, and save an estimated $10 billion annually.
Why Health Price Regulations in California are Misguided
Imposing uniform payment rates is dangerous and misguided, writes Trish and Goldman in the Sacramento Bee.
Accelerating Alzheimer’s Disease Drug Innovations from the Research Pipeline to Patients
Goldman, Fillit, and Neumann outline policy options that would lead to more innovation.